Researcher.Life Logo

Frontiers in Clinical Diabetes and Healthcare : Impact Factor & More

eISSN: 2673-6616
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Frontiers in Clinical Diabetes and Healthcare Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
Overview
Publisher Frontiers Media S.A.
Language English
Article Processing ChargesUSD 1900
Publication Time13
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 13
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Frontiers in Clinical Diabetes and Healthcare ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Frontiers in Clinical Diabetes and Healthcare

Yoga interventions and randomized controlled trials: key issues and the centered impact on sedentary lifestyle-associated cardiometabolic disorders
  • 24 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Hemichorea associated with non-ketotic hyperglycemia: a case report and literature review
  • 24 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Platelet-rich plasma combined with multimodal therapy for diabetic foot ulcer with tophi: a case report
  • 21 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Impact of integrative therapies on glycemic control in type 1 diabetes: a systematic review and global research landscape
  • 20 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Observational studies on the association of outpatient antidiabetic medication use and COVID-19 outcomes: are the findings more relevant to diabetes management than to COVID-19 pathology? A mini-review
  • 14 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
The role of chromogranin A cleavage products in onset of type 1 and 2 diabetes
  • 13 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Yoga interventions and randomized controlled trials: key issues and the centered impact on sedentary lifestyle-associated cardiometabolic disorders
  • 24 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Hemichorea associated with non-ketotic hyperglycemia: a case report and literature review
  • 24 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Platelet-rich plasma combined with multimodal therapy for diabetic foot ulcer with tophi: a case report
  • 21 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Impact of integrative therapies on glycemic control in type 1 diabetes: a systematic review and global research landscape
  • 20 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
Observational studies on the association of outpatient antidiabetic medication use and COVID-19 outcomes: are the findings more relevant to diabetes management than to COVID-19 pathology? A mini-review
  • 14 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare
The role of chromogranin A cleavage products in onset of type 1 and 2 diabetes
  • 13 Apr 2026
  • Frontiers in Clinical Diabetes and Healthcare

FAQs on Frontiers in Clinical Diabetes and Healthcare